Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Retina Institute of Hawaii provides advanced diagnostic and therapeutic services for a range of retinal diseases. It was among the first in the U.S. to implant the FDA-approved Argus II "bionic eye" device for patients with retinitis pigmentosa. The clinic participates in clinical trials and offers state-of-the-art care using both established treatments and innovative technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retina Institute of Hawaii.